Blinatumomab for B-cell ALL Relapse, IVIG for MIS-C, Review of Irritable Bowel Syndrome, and more
Editor’s Summary by Mary McDermott, MD, Deputy Editor of JAMA, the Journal of the American Medical Association, for the March 2, 2021 issue
JAMA Editor’s Summary
Blinatumomab for B-cell ALL Relapse, IVIG for MIS-C, Review of Irritable Bowel Syndrome, and more
Editor's Summary by Mary McDermott, MD, Deputy Editor of JAMA, the Journal of the American Medical Association, for the
March 2, 2021
Follow JAMA Editor’s Summary on social!
You may also like
The Latest Health Podcasts. Delivered to Your Inbox.
Join Our NewsletterWe gratefully acknowledge the many organizations that have generously supported our podcasts and platform.
Network Sponsors and Advertisers
Event and Media Partners
